We intended to use a random-effect meta-analysis model in efficacy outcomes comparisons since the interventions in studies are not the same drug, which explains heterogeneity if it is noted
Adherence remains an important challenge, but it may not be sufficient for critical disease activity or advanced fibrosis (101)
recently suggested that these treatments have a place in the healthcare system, but whether and how access to these medications will change under the second Trump administration remains in the balance
According to NICE guidance (NG28), GLP-1 receptor agonists are recommended as treatment options for type 2 diabetes when certain criteria are met
To show the outlines of acinar cells, we used Alexa Fluor 488 conjugated Wheat Germ Agglutinin (1:200) as counterstaining (W11261, Thermo Fisher, Waltham, MA, USA)